Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03544866 · ClinicalTrials.gov registry record
The Impact of Pediatric Skin Disorders: The "Big" Study
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 1,666
- Enrollment target
NCT03544866: Completed study, sponsored by Northwestern University.
NCT03544866 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 1,666 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03544866 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 1,666 participants
- Enrollment target
Study Summary
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Primary Outcome
Measure the stigma experienced by children as a function of the child's perceived skin lesion visibility using the altered Neuro-QoL stigma tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,666 participants |
| Start Date | 2018-11-16 |
| Est. Completion | 2022-01-31 |
What the finished NCT03544866 record still lists
NCT03544866 is an observational study that tracks outcomes without assigning an intervention. Its 1,666 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03544866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03544866 about?
NCT03544866 is a clinical study titled "The Impact of Pediatric Skin Disorders: The "Big" Study". This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
What is the current status of trial NCT03544866?
This trial is currently completed. The enrollment target is 1,666 participants. The study started on 2018-11-16. Estimated completion is 2022-01-31.
Who is sponsoring clinical trial NCT03544866?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06644625 · 1,665 participants
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- NCT06034405 · 1,663 participants
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT06401330 · 1,656 participants · Phase 3
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI